Figure 2
From: Genetic alterations and protein expression of KIT and PDGFRA in serous ovarian carcinoma
Overall survival in patients with serous ovarian carcinoma in relation to KIT expression (A) and PDGFRA expression (B) by immunohistochemistry. Disease-free survival in patients with serous ovarian carcinoma in relation to PDGFRA expression (C).
